ME01514B - Inhibitori histonske deacetilaze sa spojenom aktivnosti protiv histonskih deacetilaza klase-l i klase-IIB u kombinaciji sa inhibitorima proteasoma - Google Patents

Inhibitori histonske deacetilaze sa spojenom aktivnosti protiv histonskih deacetilaza klase-l i klase-IIB u kombinaciji sa inhibitorima proteasoma

Info

Publication number
ME01514B
ME01514B MEP-2013-15A MEP1513A ME01514B ME 01514 B ME01514 B ME 01514B ME P1513 A MEP1513 A ME P1513A ME 01514 B ME01514 B ME 01514B
Authority
ME
Montenegro
Prior art keywords
class
inhibitors
histone
combination
combined activity
Prior art date
Application number
MEP-2013-15A
Other languages
English (en)
Inventor
Janine Arts
Peter Willem Jan Hellemans
Michel Marie François JANICOT
Martin John Page
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Priority claimed from PCT/EP2007/059518 external-priority patent/WO2008031817A2/en
Publication of ME01514B publication Critical patent/ME01514B/me

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Ovaj pronalazak se odnosi na inhibitore histonske deacetilaze (HDAC) sa spojenom aktivnosti protiv histonskih deacetilaza iz klase-I i klase-II. Pronalazak se odnosi na kombinacije i kompozicije koje obuhvataju pomenute inhibitore, kao i na njihovu upotrebu, kao lekove, na primer kao lek koji inhibira hematopoetske tumore poput limfoma i leukemija.
MEP-2013-15A 2006-09-15 2007-09-11 Inhibitori histonske deacetilaze sa spojenom aktivnosti protiv histonskih deacetilaza klase-l i klase-IIB u kombinaciji sa inhibitorima proteasoma ME01514B (me)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP06120726 2006-09-15
US91589507P 2007-05-03 2007-05-03
PCT/EP2007/059518 WO2008031817A2 (en) 2006-09-15 2007-09-11 Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors
EP07803397A EP2066327B1 (en) 2006-09-15 2007-09-11 Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors

Publications (1)

Publication Number Publication Date
ME01514B true ME01514B (me) 2014-04-20

Family

ID=41040414

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2013-15A ME01514B (me) 2006-09-15 2007-09-11 Inhibitori histonske deacetilaze sa spojenom aktivnosti protiv histonskih deacetilaza klase-l i klase-IIB u kombinaciji sa inhibitorima proteasoma

Country Status (12)

Country Link
CN (1) CN101516374B (me)
BR (1) BRPI0716992A2 (me)
DK (1) DK2066327T3 (me)
ES (1) ES2399670T3 (me)
ME (1) ME01514B (me)
NZ (1) NZ575030A (me)
PT (1) PT2066327E (me)
RS (1) RS52638B (me)
SG (1) SG177219A1 (me)
SI (1) SI2066327T1 (me)
UA (1) UA97249C2 (me)
ZA (1) ZA200901818B (me)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8957066B2 (en) * 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
CN107095871A (zh) * 2016-02-22 2017-08-29 中国科学院上海巴斯德研究所 Quisinostat，一种新型的高效抗疟药物
WO2018017858A1 (en) * 2016-07-20 2018-01-25 The Trustees Of Columbia University In The City Of New York Histone acetyltransferase activators and compositions and uses thereof
CN114409638B (zh) * 2022-02-09 2023-02-14 深圳大学 组蛋白去乙酰化酶8选择性降解剂、制备方法及其在抗肿瘤活性中的应用
CN115028678B (zh) * 2022-07-08 2024-09-06 杭州医学院 基于vhl配体诱导bcr-abl蛋白降解的双功能分子及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1781639B1 (en) * 2004-07-28 2012-01-25 Janssen Pharmaceutica NV Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase

Also Published As

Publication number Publication date
PT2066327E (pt) 2013-02-06
NZ575030A (en) 2012-07-27
CN101516374B (zh) 2013-04-24
SG177219A1 (en) 2012-01-30
ZA200901818B (en) 2010-05-26
SI2066327T1 (sl) 2013-04-30
DK2066327T3 (da) 2013-02-11
CN101516374A (zh) 2009-08-26
ES2399670T3 (es) 2013-04-02
UA97249C2 (ru) 2012-01-25
BRPI0716992A2 (pt) 2013-09-17
RS52638B (en) 2013-06-28

Similar Documents

Publication Publication Date Title
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
ECSP056253A (es) Composicion farmaceutica que contiene un inhibidor de histona desacetilasa
EA201200550A1 (ru) Фармацевтические композиции, включающие bi-1356 и метформин
ATE516041T1 (de) Synergistische zusammensetzungen mit fk-228
TW200800987A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
UA109786C2 (xx) Гетероциклічні сполуки як агоністи ір-рецептора
CL2007001391A1 (es) Compuestos derivados de pirrolidinas sustituidas, inhibidores del factor xa y/o inhibidores sobre la serina proteasa; composicion farmaceutica que comprende a dichos compuestos; proedimiento para preparar la composicon farmaceutica; y uso de los compuestos preparar un medicamneto con un efecto antitrombotico
TW200728285A (en) Diacylindazole derivatives as inhibitors of lipases and phospholipases
EA200970081A1 (ru) Соединения, обладающие потенциирующим действием в отношении активности этионамида, и их применения
TW200722421A (en) Azole derivatives as inhibitors of lipases and phospholipases
MX2014011827A (es) Inhibidores de 1,3,4 - oxadiazol y 1,3,4 - tiadiazol b-lactamasa.
EA200701790A1 (ru) Твёрдый фармацевтический дозированный состав
CR10663A (es) 4-[4-({[4-cloro-3-(trifluorometil)fenil]carbamoil}amino)-3-fluorofenoxi]-n-metilpiridina-2-carboxamida monohidrato
CL2007002167A1 (es) Compuestos derivados de indol, antagonistas iap; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de cancer.
ECSP088904A (es) Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
CY1126067T1 (el) Συντηγμενες πυρρολινες που δρουν σαν ειδικοι για ουβικιτινη αναστολεις πρωτεασης 30 (usp30)
TW200730513A (en) Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
ME01514B (me) Inhibitori histonske deacetilaze sa spojenom aktivnosti protiv histonskih deacetilaza klase-l i klase-IIB u kombinaciji sa inhibitorima proteasoma
ECSP088515A (es) Mezclas fungicidas que contienen boscalida y pirimetanilo
CY1112122T1 (el) Συνθεση σφαιριδιου λιποϊκου οξεος
CY1108231T1 (el) Σταθερη στερεα δοσολογικη μορφη περιλαμβανουσα δεσμοπρεσσινη
MY142792A (en) Azolopyridin-2-one derivatives as inhibitors of lipases and phospholipases
TW200716577A (en) Benzooxazol-2-one derivatives as inhibitors of lipases and phospholipases
CY1115516T1 (el) Φαρμακευτικη συνθεση που περιεχει ενα συνδυασμο ενος μη στεροειδικου αντιφλεγμονωδους παραγοντα και ενος αντισπασμωδικου παραγοντα
CY1109865T1 (el) Συνθεσεις βαλσαρτανης